Tag Archives: Business

Drive Thru Enticement

Sip gently.  Or risk drinking conventionally.

“What a deal!  Drive thru.  Free straw with drink purchase.”
Image courtesy of http://imgur.com/LyLZimV.


Nissan Frontier Plane Landing Rescue

Great commercial.  Will your next truck be a Nissan Frontier now?  Business at Nissan is sure to pick up, if enough people buy the message.

Nissan Frontier Landing Gear Commercial

October 7, 2011

Gaining Entry To The Business

Trying to enter a business can be tough sometimes.

“Push And Pull.  Push.  If that doesn’t work.  Pull.  If that doesn’t work.  We must be closed.”
Image courtesy of http://www.signpictures.net/pictures/Push_And_Pull.htm.

Burger King Folds At Lunch

A Burger King sigh was overheard as the lunch time crowd headed to McDonald’s.

“Poor Burger King.  Oh you’re going to McDonald’s… Okay.”
Image courtesy of http://imgur.com/gallery/z0OKq.

Sometimes 20 Minutes Is Not Enough Time For Business

Signs can be good for a business.

Assuming they advertise accordingly.

“What I do when I go to the bathroom with my laptop…”
Image courtesy of http://imgur.com/gallery/e4xp7.

Dispensing Medicine Used To Be Easy

Walgreen’s New Battle: Winning Back Express Script Customers

regaining customers lost from its contract dispute with Express Scripts (ESRX) is going to be a tough sled… even though Walgreen renewed its relationship with Express Scripts effective two weeks ago.

In June of last year, Walgreen and Express Scripts began a battle over payment issues, which continued through the fall open enrollment season of 2011 and ended Jan. 1 of this year with the two parting ways. That left millions of Americans with Express Scripts drug plans looking for a new pharmacy.

Express Scripts is a pharmacy benefit manager, or PBM, that works as a middleman between drug-makers and employers when it comes to buying drugs. PBMs pay pharmacies to dispense the drugs.

Walgreen said fourth quarter sales fell 5 percent to $17.1 billion.  Prescription sales – 63 percent of company sales in the quarter – fell 8.1 percent as the company filled fewer prescriptions thanks largely to the Express Scripts fallout. Walgreen said it filled 188 million prescriptions, or a drop of 6.9 percent.

Walgreen’s got a little too greedy, and got a taste of its own medicine.  So now Walgreen’s has to hustle and regain customer loyalty and work with the middleman that funnels the business in their direction, Express Scripts.  Otherwise, go poor.

It would never have come to this if things were just like back in the day.   When doctors had all the medicines you might need in their black bag of mystery items.  No middleman.  No pharmacy.  No insurance company.  No co- pays.  Treatment right out of the bag.  Just like the doctor ordered.   

“The good old days.  Cocaine, heroin, opium, morphine…we called that medicine.”
Image courtesy of http://imgur.com/gallery/iQcWk.


Government Policy Scaring Business Into Paralysis

Business’s real problem: Uncertainty, uncertainty, uncertainty.  Fortune/CNN Money. 

An excellent descriptive on the state of economic affairs in America nowadays. 

The key word is “paralysis.”  Tough to make a move in unpredictable times.  When those with money are unsure about letting go to invest, spend, and hire as they please, then the great big wheels of the economy start dragging down painfully.

Economic uncertainty, especially policy uncertainty, is greater than it has been in many years. And if you’re wondering why the U.S. economy is barely moving or why millions of workers can’t find jobs, extraordinary uncertainty is a major part — maybe the largest part — of the answer.

High uncertainty creates a loop of paralysis, and that’s what we’re in right now. Policymakers have no idea what’s going to happen, so they sit on their hands, as the Federal Reserve did recently. “Nearly all participants” in the latest Federal Open Market Committee meeting said that the economic outlook was more uncertain than it had been over the past 20 years, according to the minutes; the committee took no action, and the Dow dropped. The minutes also reported that business leaders were telling committee members that “heightened uncertainty” had led them “to put potential investment projects on hold until the uncertainty is resolved.” And what were those business leaders uncertain about? Government policy. An index of policy uncertainty created by economists at Stanford and the University of Chicago backs their view, showing that policy uncertainty has been much higher in recent months than during the previous 25 years.


Making Toothpicks From Start To Finish

Interesting.  How toothpicks are made.  Lots more to it that just whittling down some wood.  Skip the intro and start watching at 1:34.  Interesting. 

From Discovery.

How It’s Made: Toothpicks

 January 18, 2009

McDonald’s Boosts Profits After Facelift

McDonald’s profits boosted by store revamps.  BBC. 

Spruce things up a bit, and they will come.  And spend more.   Appearances and different menu items seem to have helped McDonald’s enjoy rosier profits.   

McDonald’s profits rose 5% in the first quarter to $1.27bn, helped by a revamp of its restaurants.

Sales at US stores that have been open at least 13 months rose 8.9% in the quarter.

New look.  New menu items.  More money.  Simple concepts applied to turn a profit.   


Big Business Eyelashes Are Coming To Congress

The competition appears to be right behind a big money-making business. 

Drugmaker’s Eyelash Fight Reaches Congress.  Roll Call. 

Allergan makes Latisse (R), an eyelash growth-enhancing medication applied to the eyelashes, to help them grow thicker and more numerous.  Whether there are few eyelashes because of medical problems, or someone feels there are just not enough eyelashes for cosmetic reasons, Latisse (R) can be used to help make them longer, darker, and thicker, and help grow more of them.  But the original manufacturer must be worried about the competition.     

With good reason.

Latisse costs $90 to $120 for a month’s supply and is not covered by insurance. It is identical to Allergan’s glaucoma drug Lumigan, an eyedrop that spurs eyelash growth as a side effect. Athena’s product, by contrast, costs $150 for a six-month supply.

The heart of the matter stems from the active ingredients called  prostaglandin analogs (PGA).   

Allergan would like Congress to require all products containing a class of ingredients known as prostaglandin analogs, or PGAs, to be approved and sold as drugs. Latisse’s active ingredient is a PGA.Can you see the price of those “cosmetics” shoot through the roof, and into the consumer’s pocketbooks? 

Can you see the price of those “cosmetics” now shoot through the roof, and out of the consumer’s pocketbooks? 

“This is a growing problem, not a static problem,” said Damon Burrows, Allergan’s vice president and associate general counsel. “The longer this proliferates, the greater the potential that other companies will try to use PGAs in products that they claim to be cosmetics.”

 Is it an attempt to change the rules of the game in the name of safety or profit?

It is hard to say exactly how many rival products contain the ingredients. Last spring, the FDA warned at least one company, Lifetech Resources, that it misbranded a similar product called RapidLash that also contained PGAs. Revitalash, another eyelash enhancer made by Athena Cosmetics Inc., also contains a PGA, according to its website.

RapidLash (R) by Rocasuba and RevitaLash (R) by Athena Cosmetics may be inexpensive alternatives.  Non-prescription too, with lower price tags.  It is understandable why Allergan would be concerned about Rocasuba, Athena, and others nipping at their heels.

Might one comment, “imitation is the sincerest form of flattery?”